Portal de investigação
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
Autores da FMUP
Participantes de fora da FMUP
- Westenberger, A
- Skrahina, V
- Usnich, T
- Beetz, C
- Vollstedt, EJ
- Laabs, BH
- Paul, JJ
- Curado, F
- Skobalj, S
- Gaber, H
- Olmedillas, M
- Bogdanovic, X
- Ameziane, N
- Schell, N
- Aasly, JO
- Afshari, M
- Agarwal, P
- Aldred, J
- Alonso-Frech, F
- Anderson, R
- Arkadir, D
- Avenali, M
- Balal, M
- Benizri, S
- Bette, S
- Bhatia, P
- Bonello, M
- Braga-Neto, P
- Brauneis, S
- Cardoso, FEC
- Cavallieri, F
- Classen, J
- Cohen, L
- Coletta, D
- Crosiers, D
- Cullufi, P
- Dashtipour, K
- Demirkiran, M
- Aguiar, PD
- De Rosa, A
- Djaldetti, R
- Dogu, O
- Ghilardi, MGD
- Eggers, C
- Elibol, B
- Ellenbogen, A
- Ertan, S
- Fabiani, G
- Falkenburger, BH
- Farrow, S
- Fay-Karmon, T
- Ferencz, GJ
- Fonoff, ET
- Fragoso, YD
- Genç, G
- Gorospe, A
- Grandas, F
- Gruber, D
- Gudesblatt, M
- Gurevich, T
- Hagenah, J
- Hanagasi, HA
- Hassin-Baer, S
- Hauser, RA
- Hernández-Vara, J
- Herting, B
- Hinson, VK
- Hogg, E
- Hu, MT
- Hummelgen, E
- Hussey, K
- Infante, J
- Isaacson, SH
- Jauma, S
- Koleva-Alazeh, N
- Kuhlenbäumer, G
- Kühn, A
- Litvan, I
- López-Manzanares, L
- Luxmore, M
- Manandhar, S
- Marcaud, V
- Markopoulou, K
- Marras, C
- McKenzie, M
- Matarazzo, M
- Merello, M
- Mollenhauer, B
- Morgan, JC
- Mullin, S
- Musacchio, T
- Myers, B
- Negrotti, A
- Nieves, A
- Nitsan, Z
- Oskooilar, N
- Öztop-Çakmak, Ö
- Pal, G
- Pavese, N
- Percesepe, A
- Piccoli, T
- de Souza, CP
- Prell, T
- Pulera, M
- Raw, J
- Reetz, K
- Reiner, J
- Rosenberg, D
- Ruiz-Lopez, M
- Ruiz Martinez, J
- Sammler, E
- Santos-Lobato, BL
- Saunders-Pullman, R
- Schlesinger, I
- Schofield, CM
- Schumacher-Schuh, AF
- Scott, B
- Sesar,
- Shafer, SJ
- Sheridan, R
- Silverdale, M
- Sophia, R
- Spitz, M
- Stathis, P
- Stocchi, F
- Tagliati, M
- Tai, YF
- Terwecoren, A
- Thonke, S
- Tönges, L
- Toschi, G
- Tumas, V
- Urban, PP
- Vacca, L
- Vandenberghe, W
- Valente, EM
- Valzania, F
- Vela-Desojo, L
- Weill, C
- Weise, D
- Wojcieszek, J
- Wolz, M
- Yahalom, G
- Yalcin-Cakmakli, G
- Zittel, S
- Zlotnik, Y
- Kandaswamy, KK
- Balck, A
- Hanssen, H
- Borsche, M
- Lange, LM
- Csoti, I
- Lohmann, K
- Kasten, M
- Brüggemann, N
- Rolfs, A
- Klein, C
- Bauer, P
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Aggressive sales tactics and scams in dementia: an exploratory study
Investigador Principal: Rui Manuel Moreira Araújo
Estudo Clínico Académico (Dementia) . 2023
Amnésia global transitória: uma síndrome enigmática
Investigador Principal: Rui Manuel Moreira Araújo
Estudo Clínico Académico . 2021
Augenblickdiagnose em Neurologia – uma reapreciação contemporânea
Investigador Principal: Rui Manuel Moreira Araújo
Estudo Clínico Académico . 2022
Anti-dementia drugs: what is the evidence in advanced stages?
Investigador Principal: Rui Manuel Moreira Araújo
Estudo Clínico Académico . 2022
Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD): a randomized clinical trial and cost-utility analysis
Investigador Principal: Rui Manuel Moreira Araújo
Ensaio Clínico Académico (Dementia) . 2022
Citar a publicação
Westenberger A,Skrahina V,Usnich T,Beetz C,Vollstedt EJ,Laabs BH,Paul JJ,Curado F,Skobalj S,Gaber H,Olmedillas M,Bogdanovic X,Ameziane N,Schell N,Aasly JO,Afshari M,Agarwal P,Aldred J,Alonso F,Anderson R,Araújo R,Arkadir D,Avenali M,Balal M,Benizri S,Bette S,Bhatia P,Bonello M,Braga P,Brauneis S,Cardoso F,Cavallieri F,Classen J,Cohen L,Coletta D,Crosiers D,Cullufi P,Dashtipour K,Demirkiran M,Aguiar PD,De Rosa A,Djaldetti R,Dogu O,Ghilardi MGD,Eggers C,Elibol B,Ellenbogen A,Ertan S,Fabiani G,Falkenburger BH,Farrow S,Fay T,Ferencz GJ,Fonoff ET,Fragoso YD,Genç G,Gorospe A,Grandas F,Gruber D,Gudesblatt M,Gurevich T,Hagenah J,Hanagasi HA,Hassin S,Hauser RA,Hernández J,Herting B,Hinson VK,Hogg E,Hu MT,Hummelgen E,Hussey K,Infante J,Isaacson SH,Jauma S,Koleva N,Kuhlenbäumer G,Kühn A,Litvan I,López L,Luxmore M,Manandhar S,Marcaud V,Markopoulou K,Marras C,McKenzie M,Matarazzo M,Merello M,Mollenhauer B,Morgan JC,Mullin S,Musacchio T,Myers B,Negrotti A,Nieves A,Nitsan Z,Oskooilar N,Öztop Ö,Pal G,Pavese N,Percesepe A,Piccoli T,de Souza CP,Prell T,Pulera M,Raw J,Reetz K,Reiner J,Rosenberg D,Ruiz M,Ruiz J,Sammler E,Santos BL,Saunders R,Schlesinger I,Schofield CM,Schumacher AF,Scott B,Sesar ,Shafer SJ,Sheridan R,Silverdale M,Sophia R,Spitz M,Stathis P,Stocchi F,Tagliati M,Tai YF,Terwecoren A,Thonke S,Tönges L,Toschi G,Tumas V,Urban PP,Vacca L,Vandenberghe W,Valente EM,Valzania F,Vela L,Weill C,Weise D,Wojcieszek J,Wolz M,Yahalom G,Yalcin G,Zittel S,Zlotnik Y,Kandaswamy KK,Balck A,Hanssen H,Borsche M,Lange LM,Csoti I,Lohmann K,Kasten M,Brüggemann N,Rolfs A,Klein C,Bauer P. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study. Brain. 2024. 147. (8):p. 2652-2667. IF:14,500. (1).
